Skip to main content
. 2021 Mar 31;26(1):19–23. doi: 10.6065/apem.2040170.085

Table 2.

Evaluation of immunohistochemical tumor markers in gonadal biopsy or gonadectomy in patients with complete androgen insensitivity syndrome

Study Markers studied No.* Positive Markers
Cools et al., [14] (2005) PLAP, OCT3/4, CD117, 15 PLAP, OCT3/4, CD 117: 1 (>12 yr)
Hannema et al., [3] (2006) PLAP, AP2γ 23 PLAP, AP2γ: 6 (4 < 12 yr)
Cheikhelar et al., [15] (2008) PLAP, CD 117 1 PLAP, CD 117: 1 (>12 yr)
Wünsch et al., [19] (2012) PLAP, CD 117, KI 67 7 0
Chaudhry et al., [5] (2017) PLAP, CD 117, OCT3/4, vimentin 9 PLAP: 6 (2<12 yr); CD 117: 3 (2<12 yr); OCT3/4: 1 (1<12 yr); Vimentin: 1 (>12 yr)
*

Number of patients submitted to immunohistochemical staining.